Akero Therapeutics Inc. (AKRO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akero Therapeutics Inc.

    NASDAQ: AKRO · Real-Time Price · USD
    47.74
    1.52 (3.29%)
    At close: Sep 26, 2025, 3:59 PM
    47.67
    -0.15%
    After-hours: Sep 26, 2025, 07:56 PM EDT

    Akero Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 340.24M 234.21M 249.77M 150.48M
    Short-Term Investments
    		 402.84M 315.8M 101.68M 37.77M
    Long-Term Investments
    		 54.75M 19.28M n/a n/a
    Other Long-Term Assets
    		 n/a n/a 108K 417K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 27.3M 9.95M n/a n/a
    Total Current Assets
    		 770.38M 559.96M 355.17M 193.58M
    Property-Plant & Equipment
    		 755K 1.03M 1.29M 1.55M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 55.51M 20.31M 1.4M 1.97M
    Total Assets
    		 825.89M 580.27M 356.57M 195.55M
    Account Payables
    		 9.03M 7.04M 7.97M 6.71M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a 205K
    Other Current Liabilities
    		 30.44M 1.3M 9.99M 17.46M
    Total Current Liabilities
    		 39.75M 19.13M 19.08M 25.13M
    Long-Term Debt
    		 35.3M 24.96M 9.54M 1.31M
    Other Long-Term Liabilities
    		 194K 54K 305K -1.31M
    Total Long-Term Liabilities
    		 36.02M 25.84M 10.93M 1.31M
    Total Liabilities
    		 75.77M 44.97M 30.01M 26.44M
    Total Debt
    		 36.12M 26.3M 10.95M 1.52M
    Book Value
    		 750.11M 535.31M 326.56M 169.11M
    Book Value Per Share
    		 11.17 10.18 8.38 4.86
    Common Stock
    		 7K 6K 5K 4K
    Retained Earnings
    		 -826.16M -574.1M -422.34M -310.3M
    Comprehensive Income
    		 948K 270K 37K -27K
    Shareholders Equity
    		 750.11M 535.31M 326.56M 169.11M
    Total Investments
    		 457.59M 335.09M 101.68M 37.77M

    Add to Watchlist